Ellevest Inc’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-95
Closed -$1.11K 888
2023
Q1
$1.11K Buy
95
+26
+38% +$331 ﹤0.01% 1562
2022
Q4
$733 Buy
69
+33
+92% +$319 ﹤0.01% 1567
2022
Q3
$0 Sell
36
-27
-43% -$357 ﹤0.01% 1701
2022
Q2
$1K Buy
63
+32
+103% +$546 ﹤0.01% 1266
2022
Q1
$1K Buy
+31
New +$880 ﹤0.01% 1299

Other funds holding HCAT

Ellevest Inc's HCAT Position: Q2 2023 in Review

Ellevest Inc sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 95 shares — an estimated $1.11K sold.

Ellevest Inc first reported a position in HCAT in Q1 2022 and held it in 5 quarters. The position peaked at $1.11K in Q1 2023. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.

  • Ellevest Inc reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 95 Health Catalyst shares in Q2 2023, an estimated $1.11K.
  • Ellevest Inc first reported a position in Health Catalyst in Q1 2022 and held it in 5 quarters.
  • Ellevest Inc's Health Catalyst position peaked at $1.11K in Q1 2023.
  • 154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.